Dr. Yiqin Wu holds a B.S. and M.S. in Chemistry from Sun Yat-sen University and a Ph.D. in Biochemistry from Boston College, USA. He has over 20 years of experience in innovative drug research and development, with several programs under his leadership advancing to clinical stages in both Europe and the United States. 

He previously served as a Postdoctoral Fellow at The Scripps Research Institute, Senior Bioscience R&D Scientist at Syrrx, Inc., Senior Scientist and Project Leader at Takeda Pharmaceuticals, Principal Scientist and Project Leader at Quanticel Pharmaceuticals, and Principal Scientist and Project Leader at Celgene. He also served as a Founding Scientist and Vice President of R&D at T2YC, and as Director of the Translational Center at the Global Health Drug Discovery Institute (GHDDI) in Beijing.